1. Home >
  2. M&A >
  3. Divestiture >
  4. United States >
  5. Massachusetts >
  6. MDxHealth Acquires Exosome Diagnostics

Divestiture • Life Science

MDxHealth Acquires Exosome Diagnostics

On August 5, 2025, MDxHealth acquired life science company Exosome Diagnostics from Bio-Techne

Acquisition Context
  • This is MDxHealth’s 3rd transaction in the Life Science sector.
  • This is MDxHealth’s 2nd transaction in the United States.
  • This is MDxHealth’s 1st transaction in Massachusetts.

Explore All 789 Divestiture Life Science Deals - Search the Database Free


M&A Deal Summary
Date August 5, 2025
Target Exosome Diagnostics
Sector Life Science
Buyer(s) MDxHealth
Sellers(s) Bio-Techne
Deal Type Divestiture

Target Company

Exosome Diagnostics

Waltham, Massachusetts, United States
Exosome Diagnostics is a developer and commercializing revolutionary, biofluid-based diagnostics to deliver personalized precision healthcare. Exosome Diagnostics is based in Waltham, Massachusetts.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

MDxHealth

Herstal, Belgium
Category Company
Founded 2003
Sector Life Science
Employees300
Revenue 90M USD (2024)
DESCRIPTION

MDxHealth is a molecular diagnostics company that develops and commercializes advanced tests for cancer assessment and the personalized treatment of patients. MDxHealth was founded in 2003 and is based in Herstal, Belgium.

Deal Context for Buyer #
Overall 3 of 3
Sector: Life Science 3 of 3
Type: Divestiture 2 of 2
State: Massachusetts 1 of 1
Country: United States 2 of 2
Year: 2025 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-08-02 Exact Sciences - DX GPS Prostate Cancer Business

Madison, Wisconsin, United States

Exact Sciences's DX GPS Prostate Cancer Business is a broadly commercialized and clinically validated test available today across the urology community. Exact Sciences's DX GPS Prostate Cancer Business is based in Madison, Wisconsin.

Buy $100M

Seller Profile 1

SELLER

Bio-Techne

Minneapolis, Minnesota, United States
Category Company
Founded 1976
Sector Life Science
Employees3,200
Revenue 1.2B USD (2024)
DESCRIPTION
Bio-Techne's corporate headquarters in Minneapolis, Minnesota.
Bio-Techne's corporate headquarters in Minneapolis, Minnesota.

Bio-Techne is a life sciences company that provides bioactive tools and resources for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. Bio-Techne was founded in 1976 and is based in Minneapolis, Minnesota.

Deal Context for Seller #
Overall 2 of 2
Sector: Life Science 2 of 2
Type: Divestiture 2 of 2
State: Massachusetts 1 of 1
Country: United States 2 of 2
Year: 2025 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-11-25 Bio-Techne - Fetal Bovine Serum Product Rights

Minneapolis, Minnesota, United States

Bio-Techne's Fetal Bovine Serum (FBS) Product Rights manufactures fetal bovine serum (FBS) product brands.

Sell -

Explore Related M&A Activity

Life Science M&A - Divestiture M&A Deals - Massachusetts M&A - United States M&A - 2025 M&A

Mergr

Solution for

Product

Company

Legal